Breaking News

U.K. Terror Threat Level Raised to Severe From Substantial
Tweet TWEET

Valeant Said to Shorten 10-Year Notes to Five in Debt Offering

Valeant Pharmaceuticals International Inc. (VRX), the drug distributor acquiring Bausch & Lomb Holdings Inc., dropped plans to issue 10-year notes as part of a $3.23 billion bond sale, instead offering five-year securities.

The shorter bonds may yield about 6.75 percent and eight-year debt may pay about 7.5 percent in a sale planned for June 27, according to a person with knowledge of the transaction, who asked not to be identified because terms aren’t set. The drugmaker had marketed the eight-year notes alongside the 10-year securities starting last week.

The company is also planning $4.05 billion in loans to help fund the purchase, according to a person with knowledge of that transaction.

To contact the reporter on this story: Sarika Gangar in New York at sgangar@bloomberg.net

To contact the editor responsible for this story Alan Goldstein at agoldstein5@bloomberg.net

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.